Ellen Sluder Cohen

US Patent:

8396571, Mar 12, 2013

Filed:

Mar 19, 2007

Appl. No.:

11/725934

Inventors:

Sorin Costiner - Somerville MA, US
Howard A. Winston - Woodbury CT, US
Jihua Wang - Unionville CT, US
Alexander I. Khibnik - Glastonbury CT, US
Ravi Rajamani - West Hartford CT, US
Thomas R. Matthis - Manchester CT, US
Ricardo A. Benitez - Bolton CT, US
Julie A. Ireland - East Hampton CT, US
Ellen Cohen - West Hartford CT, US

Assignee:

United Technologies Corporation - Hartford CT

International Classification:

G01B 3/44
G05B 13/02
G06F 15/18
G06F 19/00
G06N 5/02
G06Q 10/00
G21C 17/00

US Classification:

700 28, 700100, 702 34, 702182, 702184, 705 712, 705 724, 705 728, 706 14, 706 50

Abstract:

A process for optimizing maintenance work schedules for at least one engine includes the steps of retrieving at least one set of data for an engine from a computer readable storage medium; selecting at least one scheduling parameter for the engine; selecting a set of maintenance rules for the engine; selecting at least one maintenance work decision; selecting at least one objective for the engine; optimizing the at least one objective to generate at least one optimal maintenance work decision; and generating at least one optimal maintenance work schedule for the engine.

US Patent:

44748760, Oct 2, 1984

Filed:

Nov 9, 1981

Appl. No.:

6/319659

Inventors:

Michael E. Osband - Brookline MA
Ellen B. Cohen - Needham MA

Assignee:

Trustees of Boston University - Boston MA
Smithkline Beckman Corporation - Philadelphia PA

International Classification:

G01N 3348
G01N 3350
G01N 2164

US Classification:

435 4

Abstract:

A method for analyzing cells to determine whether they have substantial numbers of H1 and H2 histamine receptors. Also an assay kit and a composition for conducting such analyses. The assays involve fluorescent polymeric molecules to which a plurality, preferably from about 30 to about 100, of histamine or histamine blocker molecules are attached. Procedures for optimizing several variables which are essential to effective and reliable determinations.

US Patent:

53664752, Nov 22, 1994

Filed:

Dec 21, 1992

Appl. No.:

7/994195

Inventors:

Theodore N. Voss - New York NY
Barbara Curran - New York NY
Karl D. Kirk - New York NY
Ellen R. Cohen - New York NY

Assignee:

Shatzu Health Products, Inc. - New York NY

International Classification:

A61B 1700

US Classification:

606204

Abstract:

A clip is disclosed which is attached to the tragus lobe of the ear. The clip has a concave spring with two opposing jaws separated by a slot delineated by an inner surface of the concave spring. The clip also has two opposing pressure pads, each positioned on the end of a different jaw, on the inner surface of the spring, so that they are separated by an opening of the slot. The ear clip additionally has two finger tabs, each having one end attached to an end of a different jaw, on an outer surface of the spring and a second end extending away from the end of the jaw, along the outer surface of the spring.

US Patent:

54585694, Oct 17, 1995

Filed:

Jun 8, 1993

Appl. No.:

8/073923

Inventors:

Karl D. Kirk - New York NY
James R. Toleman - Palo Alto CA
Robert P. Pandorf - Tenafly NJ
Ellen R. Cohen - New York NY

Assignee:

Becton Dickinson and Company - Franklin Lakes NJ

International Classification:

A61N 130

US Classification:

604 20

Abstract:

A wearable iontophoresis system includes a control housing having a connector and an iontophoretic drug delivery patch for placement against the skin of a patient. The patch has a device for retaining the control housing connector which permits the connector to be removably attached to the patch. The control housing also has at least a power supply device and a current delivery device. The control housing has top and bottom surfaces wherein the top surface has raised, recessed and sloping regions. The thickness of the connector is tapered from a second end to a first end. Furthermore, the second end of the connector is attached to the control housing and oriented so that the first end is unattached to the control housing and proximate to the control housing bottom surface. The iontophoretic drug delivery patch includes top and bottom surfaces wherein mounted to the top surface is the device for retaining the control housing connector. The control housing connector retaining device has first and second open ends and a cavity for placement therein of the connector.